Informatie:
Fout:
ID
20777
Beschrijving
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.; ODM derived from: https://clinicaltrials.gov/show/NCT00333008
Link
https://clinicaltrials.gov/show/NCT00333008
Trefwoorden
Versies (1)
- 16-03-17 16-03-17 -
Geüploaded op
16 maart 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diffuse Large B Cell Lymphoma NCT00333008
Eligibility Diffuse Large B Cell Lymphoma NCT00333008
- StudyEvent: Eligibility
Similar models
Eligibility Diffuse Large B Cell Lymphoma NCT00333008
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Age | Morbidity cardiac
Item
60 years old and older or 18 years old and older with significant/potential cardiac morbidity
boolean
C0001779 (UMLS CUI [1])
C0220880 (UMLS CUI [2,1])
C0018787 (UMLS CUI [2,2])
C0220880 (UMLS CUI [2,1])
C0018787 (UMLS CUI [2,2])
Diffuse Large B-Cell Lymphoma Ann Arbor lymphoma staging system | International Prognostic Index
Item
diagnosis of diffuse large b cell lymphoma, ann arbor stage i-iv, any international prognostic index (ipi) score.
boolean
C0079744 (UMLS CUI [1,1])
C0432516 (UMLS CUI [1,2])
C1512894 (UMLS CUI [2])
C0432516 (UMLS CUI [1,2])
C1512894 (UMLS CUI [2])
Untreated
Item
previously untreated
boolean
C0332155 (UMLS CUI [1])
New York Heart Association Classification
Item
new york heart association (nyha) classification of class iii or better
boolean
C1275491 (UMLS CUI [1])
Ejection fraction
Item
baseline ejection fraction (ef) > 25%
boolean
C0489482 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status (ps) 0-3
boolean
C1520224 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement | Lymphoma, Non-Hodgkin
Item
unless attributable to nhl: absolute neutrophil count (anc) > 1500/ul, platelets > 100,000/ul; hemoglobin > 9.0 g/dl
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0024305 (UMLS CUI [4])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0024305 (UMLS CUI [4])
Serum total bilirubin measurement | Lymphoma
Item
bilirubin < 1.5 mg/dl (unless related to lymphoma)
boolean
C1278039 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0024299 (UMLS CUI [2])
Liver function | Transaminases | Lymphoma
Item
hepatic: transaminases < 2.5 x upper limit of normal (uln) (unless related to lymphoma)
boolean
C0232741 (UMLS CUI [1])
C0002594 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0002594 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Creatinine measurement, serum | Lymphoma
Item
creatinine < 2.5 mg/dl (unless related to lymphoma)
boolean
C0201976 (UMLS CUI [1])
C0024299 (UMLS CUI [2])
C0024299 (UMLS CUI [2])
HIV Seropositivity
Item
no hiv+ individuals
boolean
C0019699 (UMLS CUI [1])
Primary central nervous system lymphoma
Item
no primary central nervous system (cns) lymphoma
boolean
C0280803 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
no pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Communicable Disease Serious
Item
no serious active infection
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Malignant Neoplasm | Basal cell carcinoma Curative treatment
Item
history of prior malignancy within the last 5 years other than subject's original cancer diagnosis listed in inclusion criteria with the exception of curatively treated basal cell carcinoma.
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])